Bhang Inc.

BHNG

CA08862K1057

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 17:43:04 04/05/2023 BST			5-day change	1st Jan Change
0.02 ^CAD	-.--%		-.--%	-.--%

2023	Bhang Inc. completed the acquisition of 1352135 B.C. Ltd for CAD 1 million.	CI
2023	Bhang Inc. Enters into Licensing Agreement with Mana Supply Holdings	CI

Bhang Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 28, 2022

Bhang Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 0.363103 million compared to USD 0.283019 million a year ago. Net loss was USD 0.901277 million compared to USD 0.688513 million a year ago.
For the nine months, revenue was USD 1.01 million compared to USD 0.881786 million a year ago. Net loss was USD 2.74 million compared to USD 1.37 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.

Latest news about Bhang Inc.

Bhang Inc. completed the acquisition of 1352135 B.C. Ltd for CAD 1 million.	27/04/23	CI
Bhang Inc. Enters into Licensing Agreement with Mana Supply Holdings	20/04/23	CI
Bhang Inc. signed a letter of intent to acquire 1352135 B.C. Ltd for CAD 1 million.	05/03/23	CI
Bhang Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/11/22	CI
Bhang Inc. Announces Changes to Board of Directors	26/10/22	CI
Bhang Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28/08/22	CI
Bhang CEO Resigns	10/08/22	MT
Bhang Inc. Announces Executive Changes	10/08/22	CI
Bhang Inc. Announces Resignation of Jamie L. Pearson as President and Board Member	10/08/22	CI
Bhang Inc. Launches High Roller Nano-Infused Pre-Roll	14/06/22	CI
Bhang Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/06/22	CI
Bhang Inc. Auditor Raises 'Going Concern' Doubt	30/05/22	CI
Bhang Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	30/05/22	CI
Bhang Inc. Receives OU Kosher Certification in Florida	07/04/22	CI
China's cyber watchdog spells out development strategies for tech giants	10/02/22	RE
Bhang Inc. announced that it has received CAD 1.218107 million in funding	16/12/21	CI
Bhang Inc. Enters into a Strategic Partnership with INDVR Brands Inc	14/12/21	CI
Bhang Inc. Introduces Fast-Acting Hot Chocolate at HOF Palm Springs	07/12/21	CI
Bhang Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	28/11/21	CI
Bhang Inc. and Trulieve Cannabis Corp. Signs Expanded Licensing Agreement	30/09/21	CI
Bhang Inc. Enters into Letter of Intent with Green Globe Data & Research LLC	22/09/21	CI
Bhang Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	03/07/21	CI
Bhang Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	23/06/21	CI
Bhang Inc. announced that it has received CAD 1.770613 million in funding from Plant-Based Investment Corp. and other investors	21/03/21	CI
Bhang Inc. announced that it expects to receive CAD 2 million in funding from Plant-Based Investment Corp. and other investors	04/03/21	CI

Chart Bhang Inc.

Duration

Period

More charts

Company Profile

Bhang Inc. is a Canada-based consumer packaged goods company. The Companyâs products include Milk Chocolate, Ice Milk Chocolate, Caramel Mocha Milk Chocolate, Cherries & Cream Milk Chocolate, Caramel Dark Chocolate, Dark Chocolate, Fire Dark Chocolate, Blueberry Dark Chocolate, Fried Chicken & Cola Dark Chocolate, Toffee & Salt Dark Chocolate, Italian Espresso Dark Chocolate, Cookies & Cream White Chocolate, White Toast White Chocolate, and Bhang High Roller: Fig Bar. The Companyâs subsidiaries include Bhang Canada Corp., 2838301 Ontario Inc., Bhang Corporation, CB Brands, LLC, Founding Fathers' Hemp Company and Euro Brand IP Holdings, LLC.

Sector

Pharmaceuticals

More about the company